Skip to main content
Top
Published in: Molecular Imaging and Biology 5/2019

01-10-2019 | Metastasis | Commentary

Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis

Authors: Abass Alavi, Sean D. Carlin, Thomas J. Werner, Abdullah Al-Zaghal

Published in: Molecular Imaging and Biology | Issue 5/2019

Login to get access

Excerpt

In recent years, we have emphasized the limitations of positron emission tomography (PET) in imaging disorders that are beyond the capability of current instruments and available radiotracers [16]. These include imaging islets, bacteria, plaques and tangles, and atherosclerotic plaques. The spatial resolution of PET has substantially improved over the past decade, and therefore, high-quality images can be generated, particularly with specialized instruments for brain and animal studies. However, when the spatial resolution of PET instruments that are designed to image the entire body compared to that of dedicated brain scanners, it becomes quite evident that image quality deteriorates substantially due to large field of view and volume of the structures assessed. In other words, specially designed PET scanners for the brain (and possibly other small organs such as the breast) can provide images with spatial resolutions at around 4–5 mm that are similar to that of phantom studies (3–5 mm) [7, 8]. Therefore, such instruments are capable of generating images with great details of regional function in various structures in the brain. Unfortunately, conventional body scanners suffer from significant deterioration of signals emitted and this adversely affects the spatial resolution of objects examined. In particular, this becomes a major source of error in obese patients where significant scattering of the gamma rays further degrades the image quality. Since most metastatic lymph nodes reside in the trunk in most common cancers, detection of spread in such structures is a major challenge and therefore unreliable for accurate staging. Recent advances in PET instrumentation including the introduction of time-of-flight PET machines have overcome this issue to some extent [9]. We should also mention that metastatic lymph nodes are at times visualized on uncorrected images when the nodes are superficial in certain locations such as the groin and neck regions [10]. Additionally, small field of view PET imaging in the head and neck region can be employed to detect metastatic lymph nodes with higher sensitivity than that of the deeply seeded lymph nodes in the trunk. …
Literature
1.
go back to reference Cheng G, Werner TJ, Newberg A, Alavi A (2016) Failed PET application attempts in the past, can we avoid them in the future? Mol Imaging Biol 18:797–802CrossRefPubMed Cheng G, Werner TJ, Newberg A, Alavi A (2016) Failed PET application attempts in the past, can we avoid them in the future? Mol Imaging Biol 18:797–802CrossRefPubMed
2.
go back to reference Alavi A, Werner TJ (2017) FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future. Eur J Nucl Med Mol Imaging 44:417–420CrossRefPubMed Alavi A, Werner TJ (2017) FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future. Eur J Nucl Med Mol Imaging 44:417–420CrossRefPubMed
3.
go back to reference Alavi A, Werner TJ, Hoilund-Carlsen PF (2017) What can be and what cannot be accomplished with PET: rectifying ongoing misconceptions. Clin Nucl Med 42:603–605CrossRefPubMed Alavi A, Werner TJ, Hoilund-Carlsen PF (2017) What can be and what cannot be accomplished with PET: rectifying ongoing misconceptions. Clin Nucl Med 42:603–605CrossRefPubMed
4.
go back to reference Alavi A, Werner TJ, Hoilund-Carlsen PF (2017) What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques. J Nucl Cardiol 25:2012–2015CrossRefPubMed Alavi A, Werner TJ, Hoilund-Carlsen PF (2017) What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques. J Nucl Cardiol 25:2012–2015CrossRefPubMed
5.
go back to reference Alavi A, Werner TJ (2018) Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach. Diabetologia 61:2512–2515CrossRefPubMed Alavi A, Werner TJ (2018) Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach. Diabetologia 61:2512–2515CrossRefPubMed
6.
go back to reference Hess S, Alavi A, Werner T, Hoilund-Carlsen PF (2018) Molecular imaging of bacteria in patients is an attractive fata morgana, not a realistic option. J Nucl Med 59:716–717CrossRefPubMed Hess S, Alavi A, Werner T, Hoilund-Carlsen PF (2018) Molecular imaging of bacteria in patients is an attractive fata morgana, not a realistic option. J Nucl Med 59:716–717CrossRefPubMed
7.
go back to reference Braem A, Llatas MC, Chesi E et al (2004) Feasibility of a novel design of high resolution parallax-free Compton enhanced PET scanner dedicated to brain research. Phys Med Biol 49:2547–2562CrossRefPubMed Braem A, Llatas MC, Chesi E et al (2004) Feasibility of a novel design of high resolution parallax-free Compton enhanced PET scanner dedicated to brain research. Phys Med Biol 49:2547–2562CrossRefPubMed
8.
go back to reference Zaidi H, Thompson C (2009) Evolution and developments in instrumentation for positron emission mammography. PET Clin 4:317–327CrossRefPubMed Zaidi H, Thompson C (2009) Evolution and developments in instrumentation for positron emission mammography. PET Clin 4:317–327CrossRefPubMed
9.
go back to reference Daube-Witherspoon ME, Surti S, Perkins AE, Karp JS (2014) Determination of accuracy and precision of lesion uptake measurements in human subjects with time-of-flight PET. J Nucl Med 55:602–607CrossRefPubMedPubMedCentral Daube-Witherspoon ME, Surti S, Perkins AE, Karp JS (2014) Determination of accuracy and precision of lesion uptake measurements in human subjects with time-of-flight PET. J Nucl Med 55:602–607CrossRefPubMedPubMedCentral
10.
go back to reference Houseni M, Chamroonrat W, Basu S et al (2009) Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphoma. Hell J Nucl Med 12:5–9PubMed Houseni M, Chamroonrat W, Basu S et al (2009) Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphoma. Hell J Nucl Med 12:5–9PubMed
11.
go back to reference Czerniecki BJ, Bedrosian I, Faries M, Alavi A (2001) Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology. Semin Nucl Med 31:158–164CrossRefPubMed Czerniecki BJ, Bedrosian I, Faries M, Alavi A (2001) Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology. Semin Nucl Med 31:158–164CrossRefPubMed
12.
go back to reference Cheng G, Kurita S, Torigian DA, Alavi A (2011) Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 38:562–575CrossRefPubMed Cheng G, Kurita S, Torigian DA, Alavi A (2011) Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 38:562–575CrossRefPubMed
13.
go back to reference Kwee TC, Basu S, Torigian DA, Saboury B, Alavi A (2011) Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting. Eur J Nucl Med Mol Imaging 38:1353–1366CrossRefPubMed Kwee TC, Basu S, Torigian DA, Saboury B, Alavi A (2011) Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting. Eur J Nucl Med Mol Imaging 38:1353–1366CrossRefPubMed
14.
go back to reference Rischpler C, Beck TI, Okamoto S, Schlitter AM, Knorr K, Schwaiger M, Gschwend J, Maurer T, Meyer PT, Eiber M (2018) 68Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging. J Nucl Med 59:1406–1411CrossRefPubMed Rischpler C, Beck TI, Okamoto S, Schlitter AM, Knorr K, Schwaiger M, Gschwend J, Maurer T, Meyer PT, Eiber M (2018) 68Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging. J Nucl Med 59:1406–1411CrossRefPubMed
15.
go back to reference Fuster D, Chiang S, Johnson G, Schuchter LM, Zhuang H, Alavi A (2004) Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 45:1323–1327PubMed Fuster D, Chiang S, Johnson G, Schuchter LM, Zhuang H, Alavi A (2004) Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 45:1323–1327PubMed
16.
go back to reference Houshmand S, Salavati A, Segtnan EA, Grupe P, Hoilund-Carlsen PF, Alavi A (2016) Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin 11:65–84CrossRefPubMed Houshmand S, Salavati A, Segtnan EA, Grupe P, Hoilund-Carlsen PF, Alavi A (2016) Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings. PET Clin 11:65–84CrossRefPubMed
Metadata
Title
Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis
Authors
Abass Alavi
Sean D. Carlin
Thomas J. Werner
Abdullah Al-Zaghal
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Molecular Imaging and Biology / Issue 5/2019
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-018-01311-4

Other articles of this Issue 5/2019

Molecular Imaging and Biology 5/2019 Go to the issue